Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Agios Pharmaceuticals Inc., 3 years.
Agios Pharmaceuticals Inc.
Director
Neogen Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +2,816 | — | — |
| Jun 13, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +1,976 | — | — |
| Oct 27, 2025 | Neogen Corporation | Option exercise | +1,777 | $6.19 | $11,000 |
| Oct 27, 2025 | Neogen Corporation | Option exercise | +2,025 | $6.19 | $12,535 |
| Oct 23, 2025 | Neogen Corporation | Grant or award | +19,769 | $6.07 | $119,998 |
| Oct 7, 2025 | Neogen Corporation | Option exercise | +2,071 | $5.63 | $11,660 |
| Jun 20, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,120 | — | — |
| Jun 13, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +1,977 | — | — |
| Apr 22, 2025 | Neogen Corporation | Open-market purchase | +20,712 | $4.84 | $100,246 |
| Oct 28, 2024 | Neogen Corporation | Option exercise | +1,776 | $13.81 | $24,527 |
| Oct 24, 2024 | Neogen Corporation | Grant or award | +6,075 | $13.58 | $82,499 |
| Oct 7, 2024 | Neogen Corporation | Option exercise | +2,070 | $15.07 | $31,195 |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +1,976 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.